1-20 of 59
Authors: Giuseppe Lombardi
Save search
Sort by
Journal Article

The role of meningioma integrated molecular profiling to improve patient management and disclose novel therapeutic targets Open Access

PDF
Luca Bertero and others
Brain Communications, Volume 7, Issue 2, 2025, fcaf088, https://doi.org/10.1093/braincomms/fcaf088
Published: 23 February 2025
Journal Article

Relationship between glioblastoma location and O6-methylguanine-DNA methyltransferase promoter methylation percentage Open Access

PDF
Giulio Sansone and others
Brain Communications, Volume 6, Issue 6, 2024, fcae415, https://doi.org/10.1093/braincomms/fcae415
Published: 03 December 2024
Journal Article

LTBK-01. PHASE 3 STELLAR STUDY SHOWS EFLORNITHINE IMPROVES OVERALL SURVIVAL (OS) AND PROGRESSION FREE SURVIVAL (PFS) IN PATIENTS WITH RECURRENT 2021 WHO ASTROCYTOMA, IDH-MUTANT GRADE 3 Free

PDF
Howard Colman and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii1, https://doi.org/10.1093/neuonc/noae165.1301
Published: 11 November 2024
Journal Article
EDITOR'S CHOICE

Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection—Update 1 Get access

PDF
Martin J van den Bent and others
Neuro-Oncology, Volume 27, Issue 2, February 2025, Pages 331–337, https://doi.org/10.1093/neuonc/noae213
Published: 10 October 2024
Journal Article
EDITOR'S CHOICE

SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors Get access

PDF
Anthony P Y Liu and others
Neuro-Oncology, Volume 26, Issue 12, December 2024, Pages 2159–2173, https://doi.org/10.1093/neuonc/noae128
Published: 29 July 2024
Journal Article

Prolonged response to entrectinib in an adult patient with recurrent glioblastoma harboring a GOPC::ROS1 fusion Open Access

PDF
Giulia Cerretti and others
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae077, https://doi.org/10.1093/noajnl/vdae077
Published: 11 May 2024
Journal Article

3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas Free

PDF
Emeline Tabouret and others
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1302–1309, https://doi.org/10.1093/neuonc/noae037
Published: 07 March 2024
Journal Article

Vorasidenib in IDH mutant WHO grade 2 gliomas: time to stop sitting on the fence? Open Access

PDF
Angelo Dipasquale and others
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae003, https://doi.org/10.1093/noajnl/vdae003
Published: 09 January 2024
Journal Article

Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities Open Access

PDF
Marta Maccari and others
The Oncologist, Volume 29, Issue 4, April 2024, Pages 289–302, https://doi.org/10.1093/oncolo/oyad321
Published: 04 December 2023
Journal Article

CTIM-32. A PARALLEL COHORT PHASE 2 STUDY OF REGORAFENIB PLUS NIVOLUMAB FOR RECURRENT OR METASTATIC SOLID TUMORS: RESULTS IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) OR ANAPLASTIC ASTROCYTOMA (AA) Free

PDF
Matteo Simonelli and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v69–v70, https://doi.org/10.1093/neuonc/noad179.0272
Published: 10 November 2023
Journal Article

CTNI-38. RACTAC TRIAL: PHASE II MULTICENTRIC ITALIAN TRIAL ON REPOSITIONING OF THE ANTIPSYCHOTIC DRUG CHLORPROMAZINE AND ITS COMBINATION WITH TEMOZOLOMIDE IN MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS Free

PDF
Andrea Pace and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v83, https://doi.org/10.1093/neuonc/noad179.0320
Published: 10 November 2023
Journal Article

CTNI-39. REGOMA-OS: A LARGE ITALIAN MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY ANALYZING REGORAFENIB EFFICACY AND SAFETY IN RECURRENT GLIOBLASTOMA PATIENTS Free

PDF
Mario Caccese and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v83, https://doi.org/10.1093/neuonc/noad179.0321
Published: 10 November 2023
Journal Article

SYST-20 TARGETED THERAPY MATCHED TO GENOMIC ALTERATIONS (BRAFV600E, NTRK, FGFR, ROS1, PIK3CA, PTEN) IN PATIENTS WITH RECURRENT IDH WILDTYPE GLIOBLASTOMA: A REAL-LIFE COHORT ANALYSIS FROM VENETO INSTITUTE OF ONCOLOGY, PADUA (ITALY) Open Access

PDF
Marta Padovan and others
Neuro-Oncology Advances, Volume 5, Issue Supplement_3, August 2023, Pages iii31–iii32, https://doi.org/10.1093/noajnl/vdad070.123
Published: 04 August 2023
Journal Article

CTNI-15. REGORAFENIB IN COMBINATION WITH TEMOZOLOMIDE WITH OR WITHOUT RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED MGMT-METHYLATED, IDH WILDTYPE GLIOBLASTOMA: A PHASE I DOSE-FINDING STUDY (REGOMA-2) Free

PDF
Marta Padovan and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii73, https://doi.org/10.1093/neuonc/noac209.281
Published: 14 November 2022
Journal Article

CTNI-12. PHASE II MULTICENTRIC ITALIAN TRIAL ON REPOSITIONING OF THE ANTIPSYCHOTIC DRUG CHLORPROMAZINE AND ITS COMBINATION WITH TEMOZOLOMIDE IN MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS: THE RACTAC TRIAL Free

PDF
Andrea Pace and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii72, https://doi.org/10.1093/neuonc/noac209.278
Published: 14 November 2022
Journal Article

ANGI-09. BEVACIZUMAB IN ATYPICAL AND ANAPLASTIC MENINGIOMAS: THE BEMEN STUDY Free

PDF
Giulia Cerretti and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii3, https://doi.org/10.1093/neuonc/noac209.008
Published: 14 November 2022
Journal Article

BIOM-19. NEXT-GENERATION SEQUENCING (NGS) FOR IDENTIFYING ACTIONABLE MOLECULAR ALTERATIONS IN NEWLY DIAGNOSED AND RECURRENT IDHWT-GLIOBLASTOMA (GBM) PATIENTS: A LARGE MONO INSTITUTIONAL EXPERIENCE Free

PDF
Marta Padovan and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii8, https://doi.org/10.1093/neuonc/noac209.029
Published: 14 November 2022
Journal Article

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial Open Access

PDF
Andrew B Lassman and others
Neuro-Oncology, Volume 25, Issue 2, February 2023, Pages 339–350, https://doi.org/10.1093/neuonc/noac173
Published: 15 July 2022
Journal Article

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial Open Access

PDF
Antonio Omuro and others
Neuro-Oncology, Volume 25, Issue 1, January 2023, Pages 123–134, https://doi.org/10.1093/neuonc/noac099
Published: 14 April 2022
Journal Article

PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction Open Access

PDF
Giuseppe Lombardi and others
British Journal of Radiology, Volume 95, Issue 1129, 1 January 2022, 20211018, https://doi.org/10.1259/bjr.20211018
Published: 23 November 2021